Chinese COVID-19 Vaccine Induces Immune Response In Mid-Stage Tests

A coronavirus vaccine candidate developed by the Chinese Academy of Sciences (CAS) was found to be safe and triggered immune responses in early and mid-stage trials, researchers said on Tuesday.